Cargando…

Tu1265: LIVER INJURY IN HOSPITALIZED COVID-19 PATIENTS TREATED WITH TOCILIZUMAB

Detalles Bibliográficos
Autores principales: Kalligeros, Markos, Shehadeh, Fadi, Kothadia, Savan, Marino, Daniel, Mylona, Evangelia, Wands, Jack R., Mylonakis, Eleftherios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AGA Institute. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212428/
http://dx.doi.org/10.1016/S0016-5085(22)63686-2
_version_ 1784730589957455872
author Kalligeros, Markos
Shehadeh, Fadi
Kothadia, Savan
Marino, Daniel
Mylona, Evangelia
Wands, Jack R.
Mylonakis, Eleftherios
author_facet Kalligeros, Markos
Shehadeh, Fadi
Kothadia, Savan
Marino, Daniel
Mylona, Evangelia
Wands, Jack R.
Mylonakis, Eleftherios
author_sort Kalligeros, Markos
collection PubMed
description
format Online
Article
Text
id pubmed-9212428
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AGA Institute. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-92124282022-06-22 Tu1265: LIVER INJURY IN HOSPITALIZED COVID-19 PATIENTS TREATED WITH TOCILIZUMAB Kalligeros, Markos Shehadeh, Fadi Kothadia, Savan Marino, Daniel Mylona, Evangelia Wands, Jack R. Mylonakis, Eleftherios Gastroenterology AASLD Abstracts AGA Institute. Published by Elsevier Inc. 2022-05 2022-06-16 /pmc/articles/PMC9212428/ http://dx.doi.org/10.1016/S0016-5085(22)63686-2 Text en Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle AASLD Abstracts
Kalligeros, Markos
Shehadeh, Fadi
Kothadia, Savan
Marino, Daniel
Mylona, Evangelia
Wands, Jack R.
Mylonakis, Eleftherios
Tu1265: LIVER INJURY IN HOSPITALIZED COVID-19 PATIENTS TREATED WITH TOCILIZUMAB
title Tu1265: LIVER INJURY IN HOSPITALIZED COVID-19 PATIENTS TREATED WITH TOCILIZUMAB
title_full Tu1265: LIVER INJURY IN HOSPITALIZED COVID-19 PATIENTS TREATED WITH TOCILIZUMAB
title_fullStr Tu1265: LIVER INJURY IN HOSPITALIZED COVID-19 PATIENTS TREATED WITH TOCILIZUMAB
title_full_unstemmed Tu1265: LIVER INJURY IN HOSPITALIZED COVID-19 PATIENTS TREATED WITH TOCILIZUMAB
title_short Tu1265: LIVER INJURY IN HOSPITALIZED COVID-19 PATIENTS TREATED WITH TOCILIZUMAB
title_sort tu1265: liver injury in hospitalized covid-19 patients treated with tocilizumab
topic AASLD Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212428/
http://dx.doi.org/10.1016/S0016-5085(22)63686-2
work_keys_str_mv AT kalligerosmarkos tu1265liverinjuryinhospitalizedcovid19patientstreatedwithtocilizumab
AT shehadehfadi tu1265liverinjuryinhospitalizedcovid19patientstreatedwithtocilizumab
AT kothadiasavan tu1265liverinjuryinhospitalizedcovid19patientstreatedwithtocilizumab
AT marinodaniel tu1265liverinjuryinhospitalizedcovid19patientstreatedwithtocilizumab
AT mylonaevangelia tu1265liverinjuryinhospitalizedcovid19patientstreatedwithtocilizumab
AT wandsjackr tu1265liverinjuryinhospitalizedcovid19patientstreatedwithtocilizumab
AT mylonakiseleftherios tu1265liverinjuryinhospitalizedcovid19patientstreatedwithtocilizumab